Paper

The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity

Published May 1, 2013 · E. Wargent, M. Zaibi, C. Silvestri

Nutrition & Diabetes

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCTAnimal StudyVery Rigorous JournalHighly Cited

Study Snapshot

THCV improves glucose tolerance and insulin sensitivity in obese mice without significantly affecting food intake or body weight gain, offering a potential treatment for obesity-associated glucose intolerance.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity

References

Citations